Global Covid-19 Vaccination Market 2022-2026

The publisher has been monitoring the covid-19 vaccination market and the growth is expected to reduce by $ 68.35 bn during 2022-2026, progressing at a CAGR of (36.56)% during the forecast period. The report on the covid-19 vaccination market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of COVID-19 infection and favorable government initiatives.

The covid-19 vaccination market analysis includes the application segment and geographic landscape.

The covid-19 vaccination market is segmented as below:

By Application

mRNA
others

By Geographical Landscape

North America
Asia
Europe
ROW

This study identifies the rising awareness about efficient vaccination as one of the prime reasons driving the COVID-19 vaccination market growth during the next few years.

The report on COVID-19 vaccination market covers the following areas:

COVID-19 vaccination market sizing
COVID-19 vaccination market forecast
COVID-19 vaccination market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading COVID-19 vaccination market vendors that include AstraZeneca Plc, Bharat Biotech Ltd., China National Pharmaceutical Group Corp., Gamaleya National Center, Inovio Pharmaceuticals Inc., Johnson and Johnson Inc., Moderna Inc., Novavax Inc., Pfizer Inc., and Sinovac Biotech Ltd. Also, the COVID-19 vaccination market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary

Market overview

Market Landscape

Market ecosystem
Value chain analysis

Market Sizing

Market definition
Market segment analysis
Market size 2021
Market outlook: Forecast for 2021 - 2026

Five Forces Analysis

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Application

Market segments
Comparison by Application
mRNA - Market size and forecast 2021-2026
Others - Market size and forecast 2021-2026
Market opportunity by Application

Customer landscape

Geographic Landscape

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2021-2026
Asia - Market size and forecast 2021-2026
Europe - Market size and forecast 2021-2026
ROW - Market size and forecast 2021-2026
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape

Landscape disruption

Vendor Analysis

Vendors covered
Market positioning of vendors
AstraZeneca Plc
Bharat Biotech Ltd.
China National Pharmaceutical Group Corp.
Gamaleya National Center
Inovio Pharmaceuticals Inc.
Johnson and Johnson Inc.
Moderna Inc.
Novavax Inc.
Pfizer Inc.
Sinovac Biotech Ltd.

Appendix

Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits

Key Finding 1
Key Finding 2
Key Finding 3
Key Finding 5
Key Finding 6
Key Finding 7
Key Finding 8
Parent market
Market characteristics
Offerings of vendors included in the market definition
Market segments
Global - Market size and forecast 2021 - 2026 ($ million)
Global market: Year-over-year growth 2021 - 2026 (%)
Five forces analysis 2021 & 2026
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition - Five forces 2021
Application - Market share 2021-2026 (%)
Comparison by Application
mRNA - Market size and forecast 2021-2026 ($ million)
mRNA - Year-over-year growth 2021-2026 (%)
Others - Market size and forecast 2021-2026 ($ million)
Others - Year-over-year growth 2021-2026 (%)
Market opportunity by Application
Customer landscape
Market share By Geographical Landscape 2021-2026 (%)
Geographic comparison
North America - Market size and forecast 2021-2026 ($ million)
North America - Year-over-year growth 2021-2026 (%)
Asia - Market size and forecast 2021-2026 ($ million)
Asia - Year-over-year growth 2021-2026 (%)
Europe - Market size and forecast 2021-2026 ($ million)
Europe - Year-over-year growth 2021-2026 (%)
ROW - Market size and forecast 2021-2026 ($ million)
ROW - Year-over-year growth 2021-2026 (%)
Key leading countries
Market opportunity By Geographical Landscape ($ million)
Impact of drivers and challenges
Vendor landscape
Landscape disruption
Industry risks
Vendors covered
Market positioning of vendors
AstraZeneca Plc - Overview
AstraZeneca Plc - Product and service
AstraZeneca Plc - Key offerings
AstraZeneca Plc - Key customers
AstraZeneca Plc - Segment focus
Bharat Biotech Ltd. - Overview
Bharat Biotech Ltd. - Product and service
Bharat Biotech Ltd. - Key offerings
Bharat Biotech Ltd. - Key customers
Bharat Biotech Ltd. - Segment focus
China National Pharmaceutical Group Corp. - Overview
China National Pharmaceutical Group Corp. - Product and service
China National Pharmaceutical Group Corp. - Key offerings
China National Pharmaceutical Group Corp. - Key customers
China National Pharmaceutical Group Corp. - Segment focus
Gamaleya National Center - Overview
Gamaleya National Center - Product and service
Gamaleya National Center - Key offerings
Gamaleya National Center - Key customers
Gamaleya National Center - Segment focus
Inovio Pharmaceuticals Inc. - Overview
Inovio Pharmaceuticals Inc. - Product and service
Inovio Pharmaceuticals Inc. - Key offerings
Inovio Pharmaceuticals Inc. - Key customers
Inovio Pharmaceuticals Inc. - Segment focus
Johnson and Johnson Inc. - Overview
Johnson and Johnson Inc. - Business segments
Johnson and Johnson Inc. - Key offerings
Johnson and Johnson Inc. - Key customers
Johnson and Johnson Inc. - Segment focus
Moderna Inc. - Overview
Moderna Inc. - Business segments
Moderna Inc. - Key offerings
Moderna Inc. - Key customers
Moderna Inc. - Segment focus
Novavax Inc. - Overview
Novavax Inc. - Business segments
Novavax Inc. - Key offerings
Novavax Inc. - Key customers
Novavax Inc. - Segment focus
Pfizer Inc. - Overview
Pfizer Inc. - Business segments
Pfizer Inc. - Key offerings
Pfizer Inc. - Key customers
Pfizer Inc. - Segment focus
Sinovac Biotech Ltd. - Overview
Sinovac Biotech Ltd. - Product and service
Sinovac Biotech Ltd. - Key offerings
Sinovac Biotech Ltd. - Key customers
Sinovac Biotech Ltd. - Segment focus
Currency conversion rates for US$
Research Methodology
Validation techniques employed for market sizing
Information sources
List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global covid-19 vaccination market: AstraZeneca Plc, Bharat Biotech Ltd., China National Pharmaceutical Group Corp., Gamaleya National Center, Inovio Pharmaceuticals Inc., Johnson and Johnson Inc., Moderna Inc., Novavax Inc., Pfizer Inc., and Sinovac Biotech Ltd.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is .`

According to the report, one of the major drivers for this market is the increasing incidence of COVID-19 infection.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.